Driton Vela

594 total citations
15 papers, 429 citations indexed

About

Driton Vela is a scholar working on Hematology, Nutrition and Dietetics and Genetics. According to data from OpenAlex, Driton Vela has authored 15 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 6 papers in Nutrition and Dietetics and 5 papers in Genetics. Recurrent topics in Driton Vela's work include Iron Metabolism and Disorders (10 papers), Erythropoietin and Anemia Treatment (7 papers) and Trace Elements in Health (5 papers). Driton Vela is often cited by papers focused on Iron Metabolism and Disorders (10 papers), Erythropoietin and Anemia Treatment (7 papers) and Trace Elements in Health (5 papers). Driton Vela collaborates with scholars based in Kosovo, North Macedonia and Poland. Driton Vela's co-authors include Mitko Mladenov, Mjellma Rexhepi, Bonell Patiño-Escobar, Roberto Méndez‐Gallart, Gani Bajraktari, Elizabeta Gjorgievska, Artan Ahmeti, Arlind Batalli, Michael Y. Henein and Afrim Poniku and has published in prestigious journals such as British Journal of Clinical Pharmacology, Frontiers in Neuroscience and Advances in experimental medicine and biology.

In The Last Decade

Driton Vela

15 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Driton Vela Kosovo 12 187 115 109 94 79 15 429
Talina Davis United States 5 110 0.6× 137 1.2× 88 0.8× 37 0.4× 71 0.9× 5 446
Ayla Yalamanoglu United States 13 126 0.7× 123 1.1× 129 1.2× 27 0.3× 32 0.4× 20 442
Begoña Hurtado Spain 10 127 0.7× 89 0.8× 35 0.3× 24 0.3× 24 0.3× 19 404
Renate Hillermann South Africa 13 88 0.5× 122 1.1× 61 0.6× 57 0.6× 15 0.2× 23 490
Xiao Chai China 9 192 1.0× 179 1.6× 144 1.3× 33 0.4× 34 0.4× 24 419
Sayaka Moriguchi‐Goto Japan 14 121 0.6× 80 0.7× 43 0.4× 12 0.1× 90 1.1× 24 410
Ishikazu Mizuno Japan 11 119 0.6× 84 0.7× 56 0.5× 129 1.4× 12 0.2× 33 506
Imo J. Akpan United States 8 255 1.4× 168 1.5× 236 2.2× 110 1.2× 13 0.2× 21 475
Tomohiro Udagawa Japan 9 97 0.5× 198 1.7× 66 0.6× 22 0.2× 37 0.5× 25 516
Nicole M Agostino United States 8 74 0.4× 130 1.1× 42 0.4× 10 0.1× 45 0.6× 19 328

Countries citing papers authored by Driton Vela

Since Specialization
Citations

This map shows the geographic impact of Driton Vela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Driton Vela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Driton Vela more than expected).

Fields of papers citing papers by Driton Vela

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Driton Vela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Driton Vela. The network helps show where Driton Vela may publish in the future.

Co-authorship network of co-authors of Driton Vela

This figure shows the co-authorship network connecting the top 25 collaborators of Driton Vela. A scholar is included among the top collaborators of Driton Vela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Driton Vela. Driton Vela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Vela, Driton, et al.. (2021). Efficacy and safety of tocilizumab versus standard care/placebo in patients with COVID‐19; a systematic review and meta‐analysis of randomized clinical trials. British Journal of Clinical Pharmacology. 88(5). 1955–1963. 22 indexed citations
2.
Vela, Driton. (2020). Iron in the Tumor Microenvironment. Advances in experimental medicine and biology. 1259. 39–51. 15 indexed citations
3.
Vela, Driton. (2019). Keeping heart homeostasis in check through the balance of iron metabolism. Acta Physiologica. 228(1). e13324–e13324. 36 indexed citations
4.
Vela, Driton, et al.. (2018). Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications. Experimental & Molecular Medicine. 50(2). e436–e436. 63 indexed citations
5.
Vela, Driton. (2018). Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker. Molecular Medicine. 24(1). 5–5. 45 indexed citations
6.
Vela, Driton. (2018). Hepcidin, an emerging and important player in brain iron homeostasis. Journal of Translational Medicine. 16(1). 25–25. 82 indexed citations
7.
Vela, Driton. (2018). Systemic and local hepcidin as emerging and important peptides in renal homeostasis and pathology. BioFactors. 45(2). 118–134. 3 indexed citations
8.
Vela, Driton. (2018). The Dual Role of Hepcidin in Brain Iron Load and Inflammation. Frontiers in Neuroscience. 12. 740–740. 53 indexed citations
9.
Vela, Driton. (2018). Iron Metabolism in Prostate Cancer; From Basic Science to New Therapeutic Strategies. Frontiers in Oncology. 8. 547–547. 29 indexed citations
10.
11.
Vela, Driton. (2017). Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology. Laboratory Investigation. 98(3). 315–326. 32 indexed citations
12.
Vela, Driton, et al.. (2017). Low Hepcidin in Type 2 Diabetes Mellitus: Examining the Molecular Links and Their Clinical Implications. Canadian Journal of Diabetes. 42(2). 179–187. 11 indexed citations
13.
Vela, Driton, et al.. (2017). The Role of Insulin Therapy in Correcting Hepcidin Levels in Patients with Type 2 Diabetes Mellitus. Oman Medical Journal. 32(3). 195–200. 8 indexed citations
14.
Bajraktari, Gani, Arlind Batalli, Afrim Poniku, et al.. (2012). Left ventricular markers of global dyssynchrony predict limited exercise capacity in heart failure, but not in patients with preserved ejection fraction. Cardiovascular Ultrasound. 10(1). 36–36. 14 indexed citations
15.
Méndez‐Gallart, Roberto, et al.. (2006). [Platelet-rich plasma (platelet gel) in secondary alveoloplasty in cleft patients].. PubMed. 19(1). 23–6. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Talina Davis Breakdown of academic impact, for papers by Ayla Yalamanoglu Breakdown of academic impact, for papers by Begoña Hurtado Breakdown of academic impact, for papers by Renate Hillermann Breakdown of academic impact, for papers by Xiao Chai Breakdown of academic impact, for papers by Sayaka Moriguchi‐Goto Breakdown of academic impact, for papers by Ishikazu Mizuno Breakdown of academic impact, for papers by Imo J. Akpan Breakdown of academic impact, for papers by Tomohiro Udagawa Breakdown of academic impact, for papers by Nicole M Agostino
Rankless by CCL
2026